IRB Approval from Cleveland Clinic


APrevent received institutional review board (IRB) approval for English dysarthric speech collection in Cleveland Clinic. APrevent plans to enroll up to 50 patients in the first year from five different neurological disorders: stroke, Cerebral Palsy, Parkinson’s Disease, Amyotrophic Lateralsclerosis (ALS), and Multiple Sclerosis. Database from this study will be used for development of speech conversion platform for dysarthric patients to improve their speech intelligibility.